Ceramides and the skin barrier: what oral supplementation can and cannot do

The stratum corneum — the outermost layer of skin — is often described as a brick-and-mortar structure. The keratinocytes are the bricks; the lipid matrix between them is the mortar. Ceramides constitute approximately 50% of that lipid matrix by weight. They are not a cosmetic ingredient; they are a structural component of the skin barrier, responsible for preventing transepidermal water loss and blocking the entry of allergens, irritants, and pathogens.

What happens to ceramides with age

Ceramide levels in the stratum corneum decline with age. The decline is measurable by the mid-thirties and accelerates after menopause in women. The consequences are visible: increased transepidermal water loss (TEWL), impaired barrier function, increased skin sensitivity, and the characteristic dry, flaky texture of aged skin. Atopic dermatitis — eczema — is partly characterised by ceramide deficiency, and topical ceramide formulations are a standard component of eczema management.

Can oral ceramides reach the skin?

The mechanism question is the same as for oral hyaluronic acid: can a lipid molecule survive digestion and reach the skin in a biologically active form? The answer appears to be: not directly, but indirectly. Oral ceramides — particularly glucosylceramides from rice or milk — are hydrolysed in the gut to ceramide and glucose. The ceramide is absorbed and enters the circulation. Whether it is incorporated directly into the stratum corneum or acts as a signalling molecule that stimulates endogenous ceramide synthesis is not fully established. The clinical evidence, however, does not require the mechanism to be resolved.

The trial evidence

A 2022 open-label prospective study by Leo et al. (n=50) tested 40 mg/day of rice-derived ceramides for three months. The results were substantial: TEWL reduced by 36.9% on the cheek, 47.1% on the neck, and 39.2% on the arm. Stratum corneum hydration improved by 22.8% on the cheek. Wrinkle severity (WSRS) reduced by 16.7%. Notably, older participants showed greater improvement in sebum production than younger participants — suggesting the intervention is most useful in the population with the greatest ceramide deficit.

A 2024 randomised, double-blind, placebo-controlled trial by Ahn et al. (n=87) tested 600 mg/day of milk ceramides for 12 weeks. The ceramide group showed significant decreases in TEWL (1.34 g/h/m²) and significant increases in skin hydration (5.93 AU) compared to placebo. Wrinkles around the eyes also improved significantly.

TEWL reduced by 36.9–47.1% with rice ceramide supplementation. Skin hydration improved by 22.8%. These are not marginal effects — they reflect meaningful restoration of barrier function.

— Leo TK et al., Nutrients, 2022

What oral ceramides cannot do

• They cannot substitute for topical ceramide therapy in acute eczema or severely compromised barrier function. The effect is systemic and gradual, not localised and immediate.
• They cannot reverse structural skin ageing (wrinkle depth, collagen loss) — their primary effect is on barrier function and hydration, not dermal structure.
• They are not equivalent across sources: rice glucosylceramides and milk sphingomyelin have different ceramide profiles. The clinical evidence is specific to the formulations tested.